Clinical Trial Update: A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating vedolizumab in children with ulcerative colitis or Crohn's disease; recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (Entyvio) (Vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis, Crohn's Disease | Phase 3 | Status: RECRUITING